MX353024B - Compuestos de fenil carbamato para uso en la prevencion o tratamiento de epilepsia. - Google Patents
Compuestos de fenil carbamato para uso en la prevencion o tratamiento de epilepsia.Info
- Publication number
- MX353024B MX353024B MX2014008020A MX2014008020A MX353024B MX 353024 B MX353024 B MX 353024B MX 2014008020 A MX2014008020 A MX 2014008020A MX 2014008020 A MX2014008020 A MX 2014008020A MX 353024 B MX353024 B MX 353024B
- Authority
- MX
- Mexico
- Prior art keywords
- preventing
- phenyl carbamate
- treating
- epilesy
- carbamate compounds
- Prior art date
Links
- BSCCSDNZEIHXOK-UHFFFAOYSA-N phenyl carbamate Chemical class NC(=O)OC1=CC=CC=C1 BSCCSDNZEIHXOK-UHFFFAOYSA-N 0.000 title 1
- -1 phenyl carbamate compound Chemical class 0.000 abstract 3
- 206010015037 epilepsy Diseases 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/02—Carbamic acids; Salts of carbamic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/26—Polyhydroxylic alcohols containing only six-membered aromatic rings as cyclic part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/36—Polyhydroxylic alcohols containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Un compuesto fenil carbamato, una composición farmacéutica para la prevención y/o tratamiento de la epilepsia comprometiendo al compuesto fenil carbamato como un ingrediente activo, y un uso del compuesto fenil carbamato para la prevención y/o tratamiento de la epilepsia, son previstos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161580409P | 2011-12-27 | 2011-12-27 | |
PCT/KR2012/011474 WO2013100570A1 (en) | 2011-12-27 | 2012-12-26 | Phenyl carbamate compounds for use in preventing or treating epilesy |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2014008020A MX2014008020A (es) | 2014-12-08 |
MX353024B true MX353024B (es) | 2017-12-18 |
Family
ID=48655156
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014008021A MX338554B (es) | 2011-12-27 | 2012-12-26 | Compuestos de fenil carbamato para usarse en aliviar o tratar el dolor. |
MX2014008020A MX353024B (es) | 2011-12-27 | 2012-12-26 | Compuestos de fenil carbamato para uso en la prevencion o tratamiento de epilepsia. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014008021A MX338554B (es) | 2011-12-27 | 2012-12-26 | Compuestos de fenil carbamato para usarse en aliviar o tratar el dolor. |
Country Status (13)
Country | Link |
---|---|
US (6) | US20130203846A1 (es) |
EP (6) | EP2797880B1 (es) |
JP (8) | JP6089045B2 (es) |
KR (6) | KR101862203B1 (es) |
CN (6) | CN104136413B (es) |
AU (2) | AU2012360362B2 (es) |
BR (2) | BR112014015568B1 (es) |
CA (2) | CA2859129C (es) |
ES (3) | ES2710902T3 (es) |
IN (2) | IN2014MN01436A (es) |
MX (2) | MX338554B (es) |
RU (2) | RU2632659C2 (es) |
WO (6) | WO2013100566A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9018253B2 (en) | 2010-07-02 | 2015-04-28 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate compound and muscle relaxant containing the same |
CN104136413B (zh) | 2011-12-27 | 2016-10-26 | 比皮艾思药物研发有限公司 | 用于预防或治疗癫痫症的苯基氨基甲酸酯化合物 |
CN109939092B (zh) | 2013-03-12 | 2022-03-22 | 比皮艾思药物研发有限公司 | 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物 |
CN105164103B (zh) * | 2013-03-12 | 2019-12-06 | 比皮艾思药物研发有限公司 | 苯基氨基甲酸酯化合物和含有其的预防或治疗记忆缺失相关疾病的组合物 |
JP6335307B2 (ja) * | 2013-12-12 | 2018-05-30 | バイオ−ファーム ソリューションズ カンパニー リミテッド | てんかん予防または治療用スルファメート誘導体化合物 |
EP3443959A1 (en) * | 2013-12-12 | 2019-02-20 | Bio-Pharm Solutions Co., Ltd. | Sulfamate derivative compounds for use in treating or alleviating pain |
US10351519B2 (en) * | 2016-02-29 | 2019-07-16 | Bio-Pharm Solutions Co., Ltd. | Sulfamate derivative compounds, processes for preparing them and their uses |
EP3697908A1 (en) | 2017-10-16 | 2020-08-26 | Voyager Therapeutics, Inc. | Treatment of amyotrophic lateral sclerosis (als) |
KR102005019B1 (ko) | 2018-04-04 | 2019-07-31 | 한국과학기술연구원 | 뇌졸중의 예방 및 치료용 조성물 |
US20210361318A1 (en) | 2018-07-02 | 2021-11-25 | Voyager Therapeutics, Inc. | Cannula system and use thereof |
WO2020010042A1 (en) | 2018-07-02 | 2020-01-09 | Voyager Therapeutics, Inc. | Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord |
KR102427769B1 (ko) | 2020-08-07 | 2022-08-02 | 한국과학기술연구원 | 다발성 경화증 예방 또는 치료용 조성물 |
KR102531540B1 (ko) | 2020-09-18 | 2023-05-16 | 한국과학기술연구원 | 류마티스 관절염 예방 또는 치료용 조성물 |
KR102614653B1 (ko) | 2021-06-09 | 2023-12-20 | 한국과학기술연구원 | 신규한 헤테로사이클릴-페닐-메틸아민 유도체, 이의 제조방법 및 이의 다발성 경화증 예방, 개선, 또는 치료 용도 |
KR102399807B1 (ko) | 2021-08-05 | 2022-05-20 | (주)바이오팜솔루션즈 | 페닐카바메이트 결정형 및 이의 제조 방법 |
CA3227793A1 (en) | 2021-08-05 | 2023-02-09 | Yong Moon Choi | Phenylcarbamate crystalline form and method for manufacturing the same |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2884444A (en) | 1956-01-13 | 1959-04-28 | Carter Prod Inc | 2-phenyl-1,3 propane diol dicarbamate |
US2937119A (en) | 1959-06-11 | 1960-05-17 | Carter Prod Inc | Nu-monosubstituted-2, 2-dialkyl-1, 3-propanediol dicarbamates |
US3313692A (en) | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
US3265727A (en) | 1962-06-26 | 1966-08-09 | Armour Pharma | Phenyl alkyl-1, 2 dicarbamates |
US3313696A (en) | 1962-06-26 | 1967-04-11 | Armour Pharmacentical Company | Carbamate sedative compositions and method of use |
US3313699A (en) * | 1962-06-26 | 1967-04-11 | Armour Pharma | Compositions for and method of treating the central nervous system |
US3313700A (en) * | 1962-07-18 | 1967-04-11 | Armour Pharmacentical Company | Method of treating the central nervous system with substituted phenethyl carbamates and compositions therefor |
US3265728A (en) * | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
FR5671M (es) * | 1965-04-23 | 1968-01-02 | ||
US3600427A (en) | 1967-05-08 | 1971-08-17 | Anthony J Verbiscar | Phenyl carbamate latentiated phenethylamines |
JPS61271992A (ja) * | 1985-05-28 | 1986-12-02 | Central Glass Co Ltd | 光学活性ジオ−ルの製造方法 |
AU6765394A (en) * | 1993-05-25 | 1994-12-20 | Avondale Chemical Company | Process for preparing felbamate and intermediates thereto |
US5698588A (en) * | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
US20010034365A1 (en) * | 1996-01-16 | 2001-10-25 | Choi Yong Moon | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
US6242468B1 (en) * | 1997-02-27 | 2001-06-05 | Jia-He Li | Carbamate and urea compositions and neurotrophic uses |
JP3960801B2 (ja) * | 1999-11-29 | 2007-08-15 | 三菱レイヨン株式会社 | アセタールスルホネート誘導体およびその製造方法ならびにスチレンオキサイド誘導体の製造方法 |
GB0004297D0 (en) * | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
NZ527990A (en) * | 2001-02-27 | 2006-01-27 | Ortho Mcneil Pharm Inc | Carbamate compounds for use in preventing or treating neurodegenerative disorders |
PL364647A1 (en) | 2001-02-27 | 2004-12-13 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in the treatment of pain |
EE200300476A (et) | 2001-04-02 | 2003-12-15 | Astrazeneca Ab | 4-tsüanotrifluoro-3-(4-fluorofenüülsulfonüül)-2-hüdroksü-2-metüülpropiono-m-toluidii di ja PVP-d sisaldav tahke farmatseutiline kompositsioon |
DE60222552T2 (de) | 2001-06-25 | 2008-06-26 | Sk Corp. | Carbamate von 2-heterozyklischen 1,2-ethandiolen |
RU2303445C2 (ru) | 2001-07-16 | 2007-07-27 | Орто-Макнейл Фармасьютикал, Инк. | Карбаматные соединения для применения для предотвращения или лечения невропатической боли и боли, связанной с кластерной и мигреневой головной болью |
KR20090097966A (ko) * | 2001-12-21 | 2009-09-16 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | 2-(치환된 페닐)-2-하이드록시-에틸 카바메이트의 제조방법 |
FR2836915B1 (fr) * | 2002-03-11 | 2008-01-11 | Aventis Pharma Sa | Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant |
US7385076B2 (en) | 2002-05-31 | 2008-06-10 | Sun Pharmaceutical Industries Limited | Process for the preparation of phenylcarbamates |
PE20050141A1 (es) * | 2003-04-23 | 2005-04-01 | Schering Corp | DERIVADOS DE 2-ALQUINIL-Y 2-ALQUENIL-PIRAZOLO-[4,3-e]-1,2,4-TRIAZOLO-[1,5-c]-PIRIDINA COMO ANTAGONISTAS DEL RECEPTOR A2a ADENOSINA |
CA2544900A1 (en) * | 2003-11-05 | 2005-05-19 | Unimed Pharmaceuticals, Inc. | Delta-9- the treatment of multiple sclerosis |
DE602005020127D1 (de) * | 2004-04-21 | 2010-05-06 | Schering Corp | Pyrazoloä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidine als antagonisten des adenosin-a2a-rezeptors |
JP5001150B2 (ja) * | 2004-06-08 | 2012-08-15 | ファミリーズ オブ スパイナル マスキュラー アトロフィー | 脊髄性筋萎縮症のための2,4−ジアミノキナゾリン |
ES2342185T3 (es) * | 2004-09-16 | 2010-07-02 | Janssen Pharmaceutica Nv | Uso de (di)carbamatos de 2-fenil-1,2-etanodiol para el tratamiento de la epileptogenesis. |
CN101076327A (zh) * | 2004-10-15 | 2007-11-21 | 詹森药业有限公司 | 用于治疗神经变性疾病的氨基甲酸酯化合物 |
US7442438B2 (en) | 2005-05-04 | 2008-10-28 | 3M Innovative Properties Company | Wet and dry stick adhesive, articles, and methods |
TW200800954A (en) | 2006-03-16 | 2008-01-01 | Astrazeneca Ab | Novel crystal modifications |
CN101472913A (zh) * | 2006-07-28 | 2009-07-01 | 卫材R&D管理有限公司 | 肉桂酰胺化合物的前药 |
AR062095A1 (es) * | 2006-07-28 | 2008-10-15 | Eisai R&D Man Co Ltd | Profarmaco de compuesto cinamida |
AU2007307029A1 (en) * | 2006-10-06 | 2008-04-17 | Transform Pharmaceuticals, Inc. | Novel crystal of (S)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate |
CN101663026A (zh) | 2006-10-13 | 2010-03-03 | 詹森药业有限公司 | 氨基甲酸苯基烷基酯组合物 |
JP2010523468A (ja) * | 2006-10-27 | 2010-07-15 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 蝸牛及び前庭障害の処置方法 |
CN101568362A (zh) | 2006-10-30 | 2009-10-28 | 詹森药业有限公司 | 治疗抑郁症的方法 |
PE20081775A1 (es) * | 2006-12-20 | 2008-12-18 | Bristol Myers Squibb Co | Compuestos macrociclicos como inhibidores del factor viia |
MX2009010984A (es) * | 2007-04-10 | 2010-01-15 | Sgx Pharmaceuticals Inc | Moduladores de heterociclo cinasa de anillo fusionado. |
WO2009022345A1 (en) * | 2007-08-14 | 2009-02-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Phenyl carbamates for the treatment of multiple sclerosis |
US20090105498A1 (en) * | 2007-10-18 | 2009-04-23 | Porstmann Frank | Improved process for preparing 2-(substituted phenyol)-2-hydroxy-ethyl-carbamates |
EP2330899A1 (en) | 2008-08-21 | 2011-06-15 | Richter Gedeon Nyrt. | Methods for treating neuropathic pain |
JP2011219387A (ja) * | 2010-04-06 | 2011-11-04 | Kaneka Corp | イオン液体の製造方法 |
ES2711619T3 (es) * | 2010-07-02 | 2019-05-06 | Bio Pharm Solutions Co Ltd | Compuesto carbamato de fenilo y relajante muscular que contiene dicho compuesto |
US9018253B2 (en) | 2010-07-02 | 2015-04-28 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate compound and muscle relaxant containing the same |
BR112013013028B1 (pt) * | 2011-01-13 | 2021-02-09 | Bio-Pharm Solutions Co., Ltd | processo para a preparação de derivados de carbamato de fenila e composto |
CN103635472B (zh) * | 2011-02-28 | 2018-01-12 | 阵列生物制药公司 | 丝氨酸/苏氨酸激酶抑制剂 |
CN104136413B (zh) | 2011-12-27 | 2016-10-26 | 比皮艾思药物研发有限公司 | 用于预防或治疗癫痫症的苯基氨基甲酸酯化合物 |
-
2012
- 2012-12-26 CN CN201280070646.6A patent/CN104136413B/zh active Active
- 2012-12-26 WO PCT/KR2012/011469 patent/WO2013100566A1/en active Application Filing
- 2012-12-26 KR KR1020147017965A patent/KR101862203B1/ko active IP Right Grant
- 2012-12-26 EP EP12862488.9A patent/EP2797880B1/en active Active
- 2012-12-26 WO PCT/KR2012/011474 patent/WO2013100570A1/en active Application Filing
- 2012-12-26 EP EP12862021.8A patent/EP2797878B1/en active Active
- 2012-12-26 WO PCT/KR2012/011471 patent/WO2013100568A1/en active Application Filing
- 2012-12-26 KR KR1020147017116A patent/KR20140113919A/ko not_active Application Discontinuation
- 2012-12-26 AU AU2012360362A patent/AU2012360362B2/en active Active
- 2012-12-26 CA CA2859129A patent/CA2859129C/en active Active
- 2012-12-26 EP EP12862332.9A patent/EP2797879B1/en active Active
- 2012-12-26 JP JP2014549992A patent/JP6089045B2/ja active Active
- 2012-12-26 RU RU2014124028A patent/RU2632659C2/ru active
- 2012-12-26 WO PCT/KR2012/011470 patent/WO2013100567A1/en active Application Filing
- 2012-12-26 MX MX2014008021A patent/MX338554B/es active IP Right Grant
- 2012-12-26 ES ES12863856T patent/ES2710902T3/es active Active
- 2012-12-26 KR KR1020147015403A patent/KR101880584B1/ko active IP Right Grant
- 2012-12-26 JP JP2014549993A patent/JP6298765B2/ja active Active
- 2012-12-26 BR BR112014015568-2A patent/BR112014015568B1/pt active IP Right Grant
- 2012-12-26 CN CN201280070737.XA patent/CN104870421A/zh active Pending
- 2012-12-26 EP EP12861408.8A patent/EP2797877A4/en not_active Withdrawn
- 2012-12-26 CN CN201280070692.6A patent/CN104136414A/zh active Pending
- 2012-12-26 CN CN201280070782.5A patent/CN104136416B/zh active Active
- 2012-12-26 JP JP2014549994A patent/JP2015504054A/ja active Pending
- 2012-12-26 CN CN201280070738.4A patent/CN104136415B/zh active Active
- 2012-12-26 MX MX2014008020A patent/MX353024B/es active IP Right Grant
- 2012-12-26 ES ES12862332T patent/ES2716832T3/es active Active
- 2012-12-26 KR KR1020147020773A patent/KR101795563B1/ko active IP Right Grant
- 2012-12-26 ES ES12862488.9T patent/ES2624989T3/es active Active
- 2012-12-26 AU AU2012360365A patent/AU2012360365B2/en active Active
- 2012-12-26 CN CN201280070632.4A patent/CN104169253B/zh active Active
- 2012-12-26 KR KR1020147016928A patent/KR101795562B1/ko active IP Right Grant
- 2012-12-26 KR KR1020147017115A patent/KR20140113918A/ko not_active Application Discontinuation
- 2012-12-26 JP JP2014549991A patent/JP6155280B2/ja active Active
- 2012-12-26 EP EP12863856.6A patent/EP2797881B1/en active Active
- 2012-12-26 WO PCT/KR2012/011472 patent/WO2013100569A1/en active Application Filing
- 2012-12-26 WO PCT/KR2012/011475 patent/WO2013100571A1/en active Application Filing
- 2012-12-26 BR BR112014015482A patent/BR112014015482A8/pt not_active Application Discontinuation
- 2012-12-26 CA CA2858977A patent/CA2858977C/en active Active
- 2012-12-26 JP JP2014549996A patent/JP2015504055A/ja active Pending
- 2012-12-26 JP JP2014549995A patent/JP6298766B2/ja active Active
- 2012-12-26 RU RU2014124029A patent/RU2014124029A/ru unknown
- 2012-12-26 EP EP12861302.3A patent/EP2797876A4/en not_active Withdrawn
- 2012-12-27 US US13/727,661 patent/US20130203846A1/en not_active Abandoned
- 2012-12-27 US US13/727,654 patent/US9624164B2/en active Active
- 2012-12-27 US US13/727,665 patent/US9034848B2/en active Active
- 2012-12-27 US US13/727,659 patent/US9029589B2/en active Active
- 2012-12-27 US US13/727,663 patent/US9162975B2/en active Active
- 2012-12-27 US US13/727,656 patent/US20130184338A1/en not_active Abandoned
-
2014
- 2014-07-15 IN IN1436MUN2014 patent/IN2014MN01436A/en unknown
- 2014-07-15 IN IN1432MUN2014 patent/IN2014MN01432A/en unknown
-
2017
- 2017-07-21 JP JP2017141920A patent/JP2017193577A/ja active Pending
-
2018
- 2018-01-10 JP JP2018001648A patent/JP2018108996A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX353024B (es) | Compuestos de fenil carbamato para uso en la prevencion o tratamiento de epilepsia. | |
EP2883875A4 (en) | DERIVED FROM N2, N4-BIS (4- (PIPERAZIN-1-YL) PHENYL) PIRIMIDINE-2,4-DIAMINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND COMPOSITION CONTAINING THE SAME AS ACTIVE SUBSTANCE FOR PREVENTING OR TREATING CANCER | |
MY163083A (en) | Solid forms of a pharmaceutically active substance | |
TN2013000255A1 (en) | Aminoindanes amides having a high fungicidal activity and their phytosanitary compositions | |
IL233154A (en) | Compounds, pharmaceuticals containing them and their uses | |
MX2013012542A (es) | Compuestos de amida y aplicacion farmaceutica para el mismo. | |
ZA201406866B (en) | Herbicidal composition comprising uracil compound as active ingredient | |
EA201390885A1 (ru) | Азаиндолы в качестве противовирусных агентов против респираторного синцитиального вируса | |
EP2742019A4 (en) | N1-CYCLIC-AMIN-N5-SUBSTITUTED BIGUANIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH | |
MX2014014832A (es) | Pirrolopirimidona y pirrolopiridona, inhibidores de tanquirasa. | |
IT1404931B1 (it) | Composizioni oftalmiche per la somministrazione di principi attivi liposolubili . | |
WO2013055687A3 (en) | R(+)-n-formyl-propargyl-aminoindan | |
EP2970111A4 (en) | Phenyl carbamate compound and a composition for preventing or treating a nerve gas-induced disease comprising the same | |
WO2012118308A3 (ko) | 피라졸 유도체를 포함하는 심혈관 질환 예방 및 치료용 조성물. | |
PH12015501429A1 (en) | Herbicidal composition | |
MX364934B (es) | Agente para prevenir y/o tratar dolor neuropático periférico causado por fármaco contra el cáncer. | |
PH12015501400A1 (en) | Herbicidal composition comprising a cornexistin | |
WO2012002773A3 (en) | Phenylcarbamate compound and muscle relaxant containing the same | |
MX2014015345A (es) | Inhibidores piranopiridona de tanquirasa. | |
IN2014DN10669A (es) | ||
EP2871187A4 (en) | NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT | |
EP2784061A4 (en) | ACYLHYDRACO AND OXADIAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE THEREOF | |
EP3037091A4 (en) | Composition containing monoacetyldiacylglycerol compound as active ingredient for preventing or treating asthma | |
EP2910246A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF CANCER WITH ENOBLOCK AS AN ACTIVE SUBSTANCE | |
PL2476420T3 (pl) | Kompozycja farmaceutyczna o działaniu przeciwbakteryjnym i szybko gojącym do podawania zewnętrznego, sposób jej wytwarzania |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |